La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Core Molding Technologies Résultats passés
Passé contrôle des critères 2/6
Core Molding Technologies has been growing earnings at an average annual rate of 62.1%, while the Chemicals industry saw earnings growing at 13.1% annually. Revenues have been growing at an average rate of 8.2% per year. Core Molding Technologies's return on equity is 11.3%, and it has net margins of 5.1%.
Informations clés
62.1%
Taux de croissance des bénéfices
61.6%
Taux de croissance du BPA
| Chemicals Croissance de l'industrie | 12.9% |
| Taux de croissance des recettes | 8.2% |
| Rendement des fonds propres | 11.3% |
| Marge nette | 5.1% |
| Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Ventilation des recettes et des dépenses
Comment Core Molding Technologies gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 327 | 17 | 36 | 0 |
| 31 Mar 24 | 336 | 18 | 36 | 0 |
| 31 Dec 23 | 358 | 20 | 37 | 0 |
| 30 Sep 23 | 370 | 23 | 37 | 0 |
| 30 Jun 23 | 385 | 20 | 37 | 0 |
| 31 Mar 23 | 386 | 14 | 35 | 0 |
| 31 Dec 22 | 377 | 12 | 34 | 0 |
| 30 Sep 22 | 364 | 8 | 32 | 0 |
| 30 Jun 22 | 344 | 3 | 30 | 0 |
| 31 Mar 22 | 325 | 5 | 29 | 0 |
| 31 Dec 21 | 307 | 4 | 28 | 0 |
| 30 Sep 21 | 295 | 3 | 29 | 0 |
| 30 Jun 21 | 274 | 9 | 29 | 0 |
| 31 Mar 21 | 231 | 3 | 26 | 0 |
| 31 Dec 20 | 222 | 8 | 26 | 0 |
| 30 Sep 20 | 218 | 3 | 26 | 0 |
| 30 Jun 20 | 233 | -6 | 27 | 0 |
| 31 Mar 20 | 276 | -4 | 28 | 0 |
| 31 Dec 19 | 284 | -15 | 29 | 0 |
| 30 Sep 19 | 301 | -14 | 29 | 0 |
| 30 Jun 19 | 291 | -9 | 28 | 0 |
| 31 Mar 19 | 279 | -9 | 27 | 0 |
| 31 Dec 18 | 269 | -5 | 27 | 0 |
| 30 Sep 18 | 235 | 0 | 22 | 0 |
| 30 Jun 18 | 209 | 3 | 20 | 0 |
| 31 Mar 18 | 188 | 4 | 18 | 0 |
| 31 Dec 17 | 162 | 5 | 16 | 0 |
| 30 Sep 17 | 172 | 7 | 17 | 0 |
| 30 Jun 17 | 175 | 7 | 16 | 0 |
| 31 Mar 17 | 166 | 6 | 16 | 0 |
| 31 Dec 16 | 175 | 7 | 16 | 0 |
| 30 Sep 16 | 172 | 8 | 17 | 0 |
| 30 Jun 16 | 179 | 9 | 17 | 0 |
| 31 Mar 16 | 195 | 12 | 18 | 0 |
| 31 Dec 15 | 199 | 12 | 18 | 0 |
| 30 Sep 15 | 197 | 12 | 17 | 0 |
| 30 Jun 15 | 192 | 12 | 17 | 0 |
| 31 Mar 15 | 184 | 11 | 16 | 0 |
| 31 Dec 14 | 175 | 10 | 15 | 0 |
| 30 Sep 14 | 168 | 9 | 15 | 0 |
| 30 Jun 14 | 162 | 8 | 14 | 0 |
| 31 Mar 14 | 151 | 7 | 14 | 0 |
| 31 Dec 13 | 144 | 7 | 13 | 0 |
| 30 Sep 13 | 142 | 7 | 13 | 0 |
Des revenus de qualité: CMT has high quality earnings.
Augmentation de la marge bénéficiaire: CMT's current net profit margins (5.1%) are lower than last year (5.2%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: CMT has become profitable over the past 5 years, growing earnings by 62.1% per year.
Accélération de la croissance: CMT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: CMT had negative earnings growth (-16.3%) over the past year, making it difficult to compare to the Chemicals industry average (-4.8%).
Rendement des fonds propres
ROE élevé: CMT's Return on Equity (11.3%) is considered low.